≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Left hemicolectomy

Endpoint Browser

OPER_JFB43

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Operations: NOMESCO codes — ^JFB43

1 out of 7 registries used, show all original rules.

825

4. Check minimum number of events

None

825

5. Include endpoints

None

825

6. Filter based on genotype QC (FinnGen only)

825

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 825 352 473
Unadjusted period prevalence (%) 0.17 0.12 0.21
Median age at first event (years) 64.98 62.56 66.78

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
755
Matched controls
7547
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
JFB43
NOMESCO Finland
Left hemicolectomy
+∞
323.0
755
*
UJF32
NOMESCO Finland
Coloscopy
8.0
147.9
476
1329
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
35.3
110.5
144
50
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
9.9
108.3
241
340
C18.61
ICD-10 Finland
Malignant tumor of the colon descending invasive carcinoma
387.7
101.7
100
*
L01BC06
ATC
capecitabine; oral
15.7
93.8
160
127
WX302
NOMESCO Finland
Thoracal epidural anesthesy
11.6
92.6
184
204
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
36.6
85.4
110
35
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
39.2
85.2
108
32
130
Kela drug reimbursment
Malignant tumour
7.3
81.6
220
401
C18.60
ICD-10 Finland
Malignant tumor of the descending colon without histology
418.1
77.3
76
*
C18.51
ICD-10 Finland
Malignant tumor of flexura hiealis invasive carcinoma
405.8
75.1
74
*
8140/3-C18.6
ICD-O-3
Adenocarcinoma, NOS, of descending colon
768.2
72.4
70
*
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
4.4
62.7
287
929
A03FA01
ATC
metoclopramide; systemic, rectal
4.3
62.4
291
959
JFF23
NOMESCO Finland
Transversostomy
29.8
54.2
73
27
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
6.6
53.1
148
268
WX408
NOMESCO Finland
General anesthesy, balanced
3.3
48.2
326
1397
JN4BD
NOMESCO Finland
Extensive body CT
4.5
47.7
194
539
K57.2
ICD-10 Finland
Diverticular disease of large intestine with perforation and abscess
14.3
45.7
79
61
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.6
45.6
181
488
JAH00
NOMESCO Finland
Laparotomy
10.6
45.5
91
96
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
7.2
44.7
115
184
C18.50
ICD-10 Finland
Malignant tumor in flexural lienalis without histology
238.8
44.4
45
*
JFB00
NOMESCO Finland
Partial resection of small intestine
15.1
43.8
74
54
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
8.5
41.3
94
124
B01AB05
ATC
enoxaparin; parenteral
3.0
40.8
343
1658
TPH07
NOMESCO Finland
Cathetrisation of artery
4.2
39.9
170
485
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.8
38.2
342
1700
C18.79
ICD-10 Finland
Malignant tumor of the sigmoid or other unspecified histology
36.7
35.4
45
13
P01AB01
ATC
metronidazole; oral, rectal
2.7
35.1
361
1923
8140/3-C18.5
ICD-O-3
Adenocarcinoma, NOS, of splenic flexure of colon
188.7
35.1
36
*
JEA00
NOMESCO Finland
Appendectomy
5.8
34.7
105
206
D37.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Colon
11.5
32.3
61
57
A04AA02
ATC
granisetron; systemic, transdermal
5.0
32.3
110
247
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
18.6
31.8
49
28
C18.6
ICD-10 Finland
Malignant neoplasm: Descending colon
+∞
30.4
29
*
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
5.1
30.0
101
223
8140/3-C18.9
ICD-O-3
Adenocarcinoma, NOS, of colon, NOS
31.5
29.7
39
13
C18.7
ICD-10 Finland
Malignant neoplasm: Sigmoid colon
21.6
29.4
43
21
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
5.9
29.3
86
162
TPH04
NOMESCO Finland
Cathetrisation of vein
2.8
28.9
224
981
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.7
28.8
140
439
K56.7
ICD-10 Finland
Ileus, unspecified
11.1
28.7
55
53
Z93.3
ICD-10 Finland
Colostomy status
22.7
28.5
41
19
C18.69
ICD-10 Finland
Malignant tumor of colon descendens other or unspecified histology
291.8
27.9
28
*
JN4AD
NOMESCO Finland
Body CT examination
4.0
27.5
120
342
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
10.3
27.1
54
56
C18.62
ICD-10 Finland
Malignant tumor of the descending colon carcinoma of the adenoma
280.6
26.9
27
*
C18.59
ICD-10 Finland
Malignant tumor in flexura lienalis other or unspecified histology
258.2
24.8
25
*
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
6.9
24.7
63
98
JAH01
NOMESCO Finland
Laparoscopy
5.9
24.4
70
128
C18.99
ICD-10 Finland
Malignant tumor in unspecified location in the colon other or unspecified histology
39.0
24.1
30
8
JN3AD
NOMESCO Finland
Abdominal CT examination
3.8
24.0
108
315
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
9.8
23.6
48
52
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
4.3
23.4
91
232
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
8.1
22.9
52
68
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
7.4
22.8
55
79
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
7.6
22.4
53
74
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.7
22.0
78
181
JFF10
NOMESCO Finland
Loop enterostomy
26.0
21.9
30
12
H02AB02
ATC
dexamethasone; systemic
3.1
21.8
130
469
UJF30
NOMESCO Finland
Ileoscopy through colon
3.5
21.8
110
352
B01AB10
ATC
tinzaparin; parenteral
3.8
21.5
98
288
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
5.1
21.4
69
145
JWF00
NOMESCO Finland
Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery
215.7
20.7
21
*
WZC30
NOMESCO Finland
Teaching
2.8
20.6
147
597
JFB44
NOMESCO Finland
Laparoscopic left hemicolectomy
33.6
20.3
26
8
WX402
NOMESCO Finland
General anaesthesia
2.8
20.2
145
591
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
32.2
19.4
25
8
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
10.2
19.3
38
39
8140/3-C18.4
ICD-O-3
Adenocarcinoma, NOS, of transverse colon
23.3
19.2
27
12
JAL30
NOMESCO Finland
Omentectomy
11.1
19.1
36
34
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
10.5
19.1
37
37
C18.41
ICD-10 Finland
Malignant tumor of the transverse colon invasive carcinoma
21.5
18.7
27
13
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
4.9
18.7
63
139
JFG10
NOMESCO Finland
Closure of loop colostomy without resection
13.3
18.6
32
25
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
6.2
18.5
50
85
JMA10
NOMESCO Finland
Transabdominal total splenectomy
15.8
18.1
29
19
D75
ICPC
Malignant neoplasm colon/rectum
17.0
18.0
28
17
C18.5
ICD-10 Finland
Malignant neoplasm: Splenic flexure
+∞
17.8
17
*
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
8.3
17.7
39
49
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
7.2
17.7
43
63
K63.1
ICD-10 Finland
Perforation of intestine (nontraumatic)
13.5
17.6
30
23
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.4
17.3
168
802
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
4.5
17.2
62
147
K65.0
ICD-10 Finland
Acute peritonitis
9.6
16.8
34
37
N02AA05
ATC
oxycodone; systemic
2.4
16.7
158
746
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
4.6
16.6
58
133
A04AA01
ATC
ondansetron; systemic, rectal
3.6
16.5
77
230
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.5
16.2
138
615
K50.1
ICD-10 Finland
Crohn disease of large intestine
14.0
16.1
27
20
JFF30
NOMESCO Finland
Other colostomy
48.6
16.1
19
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
15.9
248
1462
N02BE01
ATC
paracetamol; systemic, rectal
2.3
15.9
654
5559
C18.72
ICD-10 Finland
Malignant tumor of sigmoid carcinoma of adenoma
14.9
15.9
26
18
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
3.6
15.9
73
216
TJF80
NOMESCO Finland
Ostomy education
11.6
15.9
29
26
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
7.8
15.8
36
48
A06AD11
ATC
lactulose; oral
2.4
15.6
153
733
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
10.7
15.3
29
28
C18.40
ICD-10 Finland
Malignant tumor of the transverse colon without histology
29.3
15.2
20
7
C18.90
ICD-10 Finland
Malignant tumor in unspecified location in the colon without histology
20.5
15.2
22
11
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
15.1
372
2582
J01MA12
ATC
levofloxacin; systemic
2.2
15.0
186
994
ZX120
NOMESCO Finland
Intravenous
2.8
14.9
101
392
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
5.6
14.7
43
81
UJG02
NOMESCO Finland
Proctoscopy
5.7
14.1
40
73
JFB50
NOMESCO Finland
Other resection of colon
30.7
13.9
18
6
J01MA02
ATC
ciprofloxacin; systemic
1.8
13.9
333
2272
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
3.8
13.5
58
162
D12.4
ICD-10 Finland
Benign neoplasm: Descending colon
6.4
13.5
35
57
JFG30
NOMESCO Finland
Closure of colostomy with resection of exteriorised loop
40.8
13.2
16
*
K50.8
ICD-10 Finland
Other Crohn disease
10.3
13.1
25
25
JFA58
NOMESCO Finland
Endoscopic dilatation of colon
28.9
13.0
17
6
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
10.7
12.8
24
23
K50.9
ICD-10 Finland
Crohn disease, unspecified
9.2
12.8
26
29
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.9
12.7
251
1592
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.1
12.5
164
889
C18.52
ICD-10 Finland
Malignant tumor of flexura lienalis carcinoma of adenoma
+∞
12.5
12
*
A06AC01
ATC
ispaghula (psylla seeds); oral
1.9
12.4
205
1213
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.8
12.3
80
303
JAH33
NOMESCO Finland
Opening of laparostomy
38.2
12.2
15
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
4.4
11.9
43
103
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
15.0
11.8
19
13
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
3.3
11.7
59
188
TPX10
NOMESCO Finland
Implantation of vascular injection port
4.7
11.6
39
87
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
6.5
11.5
29
46
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
8.5
11.4
24
29
K57.1
ICD-10 Finland
Diverticular disease of small intestine without perforation or abscess
7.4
11.3
26
36
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
4.7
11.3
38
85
JN4CD
NOMESCO Finland
Very extensive body CT
3.5
11.2
52
156
Z98.0
ICD-10 Finland
Intestinal bypass and anastomosis status
20.4
11.2
16
8
WX306
NOMESCO Finland
Lumbar epidural anesthesy
3.6
11.1
50
146
A02BC02
ATC
pantoprazole; systemic
1.7
11.1
487
3889
C19
ICD-10 Finland
Malignant neoplasm of rectosigmoid junction
10.2
11.1
21
21
JWA00
NOMESCO Finland
Repair of wound dehiscence in gastroenterological surgery
14.1
11.0
18
13
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
3.7
11.0
48
137
JFG36
NOMESCO Finland
Closure of terminal colostomy with anastomosis to rectum
44.0
10.9
13
*
JFG40
NOMESCO Finland
Revision of enterostomy or colostomy without laparotomy
15.8
10.9
17
11
JFB60
NOMESCO Finland
Resection of sigmoid colon with end colostomy
15.8
10.9
17
11
K91.4
ICD-10 Finland
Colostomy and enterostomy malfunction
28.5
10.8
14
5
JFB30
NOMESCO Finland
Right hemicolectomy
5.9
10.7
29
51
WX892
NOMESCO Finland
Monitored bed care
2.5
10.5
82
345
WX002
NOMESCO Finland
Sedation and analgesia
1.9
10.5
166
964
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
6.2
10.4
27
45
D64.9
ICD-10 Finland
Anaemia, unspecified
2.2
10.1
103
497
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.2
10.1
107
526
K55.0
ICD-10 Finland
Acute vascular disorders of intestine
8.3
9.9
21
26
JF2AB
NOMESCO Finland
Colongraphy with X-ray
26.4
9.8
13
5
Z93.2
ICD-10 Finland
Ileostomy status
26.4
9.8
13
5
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
4.3
9.8
35
84
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
6.9
9.7
23
34
JLC10
NOMESCO Finland
Distal pancreatectomy
15.3
9.5
15
10
JFB46
NOMESCO Finland
Resection of sigmoid colon
5.7
9.4
26
47
K57.0
ICD-10 Finland
Diverticular disease of small intestine with perforation and abscess
10.8
9.3
17
16
WX704
NOMESCO Finland
Intubation
2.6
9.0
65
265
JFG20
NOMESCO Finland
Closure of enterostomy with resection of exteriorised loop
18.9
9.0
13
7
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
9.0
132
742
JFF13
NOMESCO Finland
Terminal enterostomy
24.3
8.9
12
5
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
9.6
8.8
17
18
UJF34
NOMESCO Finland
Left colonoscopy
9.6
8.8
17
18
TQW11
NOMESCO Finland
Vacuum treatment of wound
4.8
8.8
28
60
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
4.6
8.7
29
65
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
4.6
8.7
29
65
K59.09
ICD-10 Finland
Constipation, unspecified
2.6
8.7
63
256
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.5
8.7
71
306
L01BC59
ATC
trifluridine, combinations; systemic
50.6
8.7
10
*
K92.1
ICD-10 Finland
Melaena
2.7
8.6
56
214
D99
ICPC
Disease digestive system other
7.1
8.6
20
29
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
16.5
8.6
13
8
JFK00
NOMESCO Finland
Division of adhesive band in intestinal obstruction
27.9
8.5
11
*
N02AX02
ATC
tramadol; systemic, rectal
1.6
8.5
328
2458
K57.9
ICD-10 Finland
Diverticular disease of intestine, part unspecified, without perforation or abscess
4.0
8.4
32
82
5621B
ICD-9 Finland
Diverticula of intestine, Colon[DIVERTICULITIS COLI SINE HAEMORRHAGIA]
8.0
8.4
18
23
KKB10
NOMESCO Finland
Excision of retroperitoneal tumour
+∞
8.3
8
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
3.1
8.3
45
153
D01
ICPC
Abdominal pain/cramps general
2.3
8.2
76
349
R4190
NOMESCO Finland
Nutritional therapy
4.1
8.1
30
75
WX882
NOMESCO Finland
High dependency care
3.8
8.1
33
90
JKA20
NOMESCO Finland
Cholecystectomy
3.5
8.1
37
111
C18.91
ICD-10 Finland
Malignant tumor of unspecified location in colon invasive carcinoma
33.7
8.1
10
*
176
Kela drug reimbursment
Regorafenib
33.7
8.1
10
*
369
Kela drug reimbursment
Regorafenib
33.7
8.1
10
*
L04AX01
ATC
azathioprine; systemic
3.2
8.1
40
128
R11
ICD-10 Finland
Nausea and vomiting
2.4
8.0
70
314
128
Kela drug reimbursment
Cancers of female genital organs
5.2
7.9
23
45
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
7.9
7.9
17
22
SPAT1262
SPAT
Handing over of treatment supplies
1.8
7.8
154
956
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
3.4
7.8
36
110
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
2.3
7.7
68
306
S18
ICPC
Laceration/cut
1.6
7.7
318
2401
TJX00
NOMESCO Finland
Punkture or biopsy in gastrointestinal endoscopy
45.4
7.7
9
*
1506
Kela drug reimbursment
The combination of trifluridine and tipiracil
45.4
7.7
9
*
3018
Kela drug reimbursment
The combination of trifluridine and tipiracil
45.4
7.7
9
*
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
7.5
7.7
17
23
1XC07
NOMESCO Finland
NA
25.3
7.6
10
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.8
7.6
141
857
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
4.7
7.6
24
52
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
10.2
7.6
14
14
A07DA03
ATC
loperamide; oral
3.0
7.5
41
141
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.1
7.4
38
125
Z43.3
ICD-10 Finland
Attention to colostomy
80.9
7.4
8
*
JFG50
NOMESCO Finland
Laparotomy with revision of enterostomy or colostomy
80.9
7.4
8
*
L03AA02
ATC
filgrastim; parenteral
4.2
7.4
26
63
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
3.3
7.3
35
110
8140/3-C18.8
ICD-O-3
Adenocarcinoma, NOS, of overlapping lesion of colon
+∞
7.3
7
*
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.2
7.3
72
343
B01AB04
ATC
dalteparin; parenteral
2.6
7.2
51
207
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.3
7.1
67
313
K43.0
ICD-10 Finland
Incisional hernia with obstruction, without gangrene
7.1
7.0
16
23
E0000UV
ATC
NA
1.5
7.0
267
1971
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
5.5
6.9
19
35
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.8
6.9
123
736
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
7.6
6.9
15
20
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
7.6
6.9
15
20
R4110
NOMESCO Finland
Physiotherapy
1.6
6.9
196
1345
XF400
NOMESCO Finland
ECG with 12 standard connections
1.7
6.9
143
900
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
6.8
6.8
16
24
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.7
6.8
28
78
K56.0
ICD-10 Finland
Paralytic ileus
6.2
6.8
17
28
L01XE21
ATC
[U] regorafenib; oral
40.4
6.8
8
*
C18.49
ICD-10 Finland
Malignant tumor of the transverse colon other or unspecified histology
40.4
6.8
8
*
Z93
ICD-10 Finland
Artificial opening status
16.9
6.8
10
6
JAG60
NOMESCO Finland
Reconstruction of abdominal wall using prosthetic material
16.9
6.8
10
6
JJB10
NOMESCO Finland
Atypcal resection of liver
16.9
6.8
10
6
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
16.9
6.8
10
6
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
4.0
6.7
25
64
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
4.5
6.7
22
50
C18
ICD-10 Finland
Malignant neoplasm of colon
22.7
6.7
9
*
JAQ00
NOMESCO Finland
Extensive excision of peritoneum
22.7
6.7
9
*
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
3.0
6.7
36
124
WW500
NOMESCO Finland
Blood transfusion
2.9
6.7
39
141
JFG29
NOMESCO Finland
Closure of terminal enterostomy with anastomosis to rectum
70.4
6.4
7
*
XX4AT
NOMESCO Finland
Other canalization with ultrasound guidance
14.5
6.4
10
7
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
8.2
6.3
13
16
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
3.0
6.3
34
118
Z51.5
ICD-10 Finland
Palliative care
2.2
6.3
63
303
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
4.8
6.3
19
40
A07EA06
ATC
budesonide; oral, local oral
3.3
6.2
29
90
WX872
NOMESCO Finland
Intensive care
2.4
6.2
48
206
TKC20
NOMESCO Finland
Catheterisation of bladder
2.1
6.1
69
350
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.6
6.1
43
173
JAD10
NOMESCO Finland
Repair of incisional hernia
6.8
6.1
14
21
QBE15
NOMESCO Finland
Excision of other superficial lesion of skin of trunk
10.1
6.0
11
11
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
10.1
6.0
11
11
JFA70
NOMESCO Finland
Suture of small intestine
10.1
6.0
11
11
3AC01
NOMESCO Finland
NA
6.1
6.0
15
25

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
376
812
7.67
183.66
8.4
4.1
ug/l
11.2
30.0
1.02
341
683
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
154
299
6.10
78.39
5.5
3.6
u/ml
58.9
4746.4
0.78
130
254
(3022145) Colonoscopy Study observation
214
758
3.46
48.68
1.7
1.3
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
419
2213
2.82
46.43
3.5
2.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
342
1681
2.77
42.75
3.5
2.4
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
568
3639
2.80
41.10
13.5
6.4
umol/l
11.0
11.9
1.23
551
3438
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
515
3150
2.69
40.77
6.1
4.1
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
255
1124
2.84
38.69
4.7
3.3
mmol/l
0.8
0.8
0.95
244
1045
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
182
679
3.16
37.14
2.7
2.2
g/l
0.2
0.2
0.52
167
633
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
380
2145
2.43
33.61
3.8
2.5
u/l
63.0
56.9
0.57
356
1964
(3024561) Albumin [Mass/volume] in Serum or Plasma
490
3115
2.41
32.83
11.7
4.7
g/l
33.0
34.9
8.34
471
2885
(3014576) Chloride [Moles/volume] in Serum or Plasma
218
966
2.71
31.98
12.2
7.1
mmol/l
104.8
104.2
1.12
212
942
(3023368) Bacteria identified in Blood by Culture
372
2128
2.36
31.35
6.1
4.3
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
229
1074
2.57
29.67
2.8
2.0
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
117
396
3.28
27.64
14.7
10.8
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
220
1056
2.48
26.81
2.9
2.4
g/l
2.3
2.3
0.07
205
970
(3013650) Neutrophils [#/volume] in Blood by Automated count
541
3777
2.26
26.55
16.8
9.1
e9/l
4.3
4.2
0.13
479
3302
(40768804) Tissue Pathology biopsy report
411
2590
2.17
25.93
2.8
2.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
208
1002
2.44
24.94
3.0
2.5
%
18.7
22.3
3.26
172
853
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
135
535
2.82
24.04
2.1
1.6
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
177
812
2.50
23.46
11.8
8.0
%
96.3
95.5
0.91
171
785
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
170
768
2.53
23.27
3.4
2.8
umol/l
9.3
8.7
0.14
157
684
(3022948) Iron [Moles/volume] in Serum or Plasma
225
1153
2.31
23.24
3.0
2.5
umol/l
10.7
12.5
3.11
209
1056
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
186
891
2.40
22.34
11.7
7.7
kpa
5.1
5.1
0.09
179
855
(3027801) Oxygen [Partial pressure] in Arterial blood
186
892
2.40
22.27
11.7
7.6
kpa
13.9
11.8
4.96
179
858
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
145
623
2.61
21.94
3.8
2.4
u/l
42.7
33.5
0.39
128
520
(3002173) Hemoglobin [Mass/volume] in Arterial blood
162
737
2.49
21.74
12.9
8.5
g/l
114.3
120.2
3.40
157
714
(3003396) Base excess in Arterial blood by calculation
184
891
2.37
21.49
11.8
7.7
mmol/l
0.3
1.4
2.69
160
701
(4035726)
143
619
2.58
21.27
1.5
1.4
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
150
669
2.52
20.94
11.3
7.3
mmol/l
1.4
1.4
0.10
144
639
(3000991) Gas panel - Venous blood
142
620
2.56
20.72
13.5
8.9
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
189
953
2.28
19.95
6.4
5.6
mmol/l
1.0
1.0
0.65
183
874
(3013826) Glucose [Moles/volume] in Serum or Plasma
550
4116
2.01
19.27
8.5
5.0
mmol/l
7.0
6.8
1.68
534
3880
(3032080) INR in Blood by Coagulation assay
444
3100
1.94
18.96
10.8
10.5
inr
1.2
1.3
0.73
112
853
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
78
262
3.18
18.48
2.9
2.5
u/ml
0.4
0.4
0.09
37
147
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
491
3571
1.93
18.26
10.4
7.0
mmol/l
1.2
1.2
3.10
432
3014
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
60
178
3.56
17.29
2.7
2.6
g/l
4.0
3.8
0.48
60
168
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
297
1863
1.93
17.05
2.9
2.2
mg/l
3.1
3.1
0.09
270
1571
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
110
473
2.53
16.40
13.7
9.7
%
0.7
0.7
0.04
110
468
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
641
5193
2.05
16.32
16.1
7.8
u/l
87.5
80.3
2.49
619
4831
(42870588) Differential panel, method unspecified - Blood
336
2233
1.85
15.85
6.7
5.6
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
108
476
2.46
15.25
13.8
9.5
%
1.2
1.4
2.49
108
471
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
445
3269
1.78
14.68
10.1
6.2
mmol/l
1.2
1.2
3.30
412
2932
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
310
2047
1.82
14.66
4.7
3.3
u/l
33.5
33.7
0.04
293
1933
(3001122) Ferritin [Mass/volume] in Serum or Plasma
378
2654
1.78
14.51
3.6
2.8
ug/l
148.1
156.7
0.23
346
2391
(3002582) Erythrocytes [#/volume] in Urine
325
2187
1.80
14.37
4.0
3.4
e6/l
49.0
113.6
1.16
253
1722
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
229
1404
1.87
13.56
4.7
4.1
ng/l
330.7
273.6
0.14
199
1178
(3019069) Monocytes/100 leukocytes in Blood
415
3054
1.72
13.03
7.7
6.0
%
8.8
8.9
0.36
382
2843
(3006504) Eosinophils/100 leukocytes in Blood
413
3043
1.72
12.84
7.3
5.8
%
2.7
2.9
0.65
381
2822
(3022096) Basophils/100 leukocytes in Blood
404
2965
1.71
12.70
7.3
5.8
%
0.6
0.6
2.00
370
2758
(3002030) Lymphocytes/100 leukocytes in Blood
417
3099
1.70
12.41
7.5
6.0
%
23.4
26.5
5.70
382
2865
(3015377) Calcium [Moles/volume] in Serum or Plasma
339
2408
1.69
11.76
7.6
3.5
mmol/l
2.4
2.3
1.18
309
2068
(3018010) Neutrophils/100 leukocytes in Blood
408
3054
1.66
11.51
7.4
5.7
%
60.4
58.1
3.07
375
2844
(3006315) Basophils [#/volume] in Blood
426
3245
1.65
11.06
7.0
5.6
e9/l
0.0
0.0
0.12
361
2794
(3030467) Casts [#/volume] in Urine by Automated count
291
2010
1.69
11.06
4.2
3.3
e6/l
0.4
0.5
0.71
220
1546
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
152
868
1.92
10.96
3.4
4.1
u/l
247.4
256.1
0.19
143
821
(3007853) Bacteria identified in Skin by Aerobe culture
145
816
1.94
10.92
2.0
1.7
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
436
3353
1.64
10.80
7.3
5.7
e9/l
0.2
0.2
0.26
378
2936
(36304419) Bacteria [Presence] in Urine
277
1907
1.68
10.56
4.2
3.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
200
1261
1.77
10.46
2.0
1.9
—
—
—
0
0
(40758558) Short blood count panel - Blood
245
1638
1.71
10.39
13.8
6.8
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
427
3289
1.62
10.34
7.1
5.7
e9/l
1.9
2.0
0.13
375
2887
(3001604) Monocytes [#/volume] in Blood
420
3228
1.61
10.22
7.0
5.6
e9/l
0.7
0.6
3.49
357
2765
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
75
336
2.36
10.16
2.4
2.0
ug/l
2.4
2.1
0.06
66
296
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
187
1174
1.77
9.86
3.5
3.1
e6/l
2.7
1.9
0.64
106
678
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
351
2600
1.61
9.84
4.0
3.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
338
2500
1.60
9.42
4.8
3.9
e6/l
168.0
110.4
0.46
258
1847
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
54
217
2.59
9.23
2.0
1.5
—
—
—
0
0
(3019060) Gas panel - Arterial blood
102
539
2.02
9.14
6.9
4.8
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
56
231
2.53
9.07
10.1
6.8
mmol/l
1.4
1.3
0.05
49
204
(3026782) Osmolality of Urine
220
1479
1.66
8.94
3.6
3.0
mosm/kgh2o
554.8
557.0
0.05
193
1254
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
191
1238
1.71
8.90
3.4
2.9
e6/l
1.2
1.1
0.13
110
735
(3031040) Bacteria [#/volume] in Urine by Automated count
538
4476
1.58
8.70
5.9
4.8
e6/l
7.6
2974.3
—
5
76
(3002256) Pathology report gross observation
141
847
1.80
8.55
1.3
1.3
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
122
702
1.87
8.50
5.4
3.8
mmol/l
2.1
2.1
0.03
103
550
(3000850) Epithelial cells [#/volume] in Urine
224
1546
1.62
8.10
3.3
2.7
e6/l
4.8
4.5
0.26
199
1358
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
387
3028
1.52
8.00
2.2
2.1
pmol/l
89.3
94.3
1.17
213
1538
(3018418) pH of Serum or Plasma
288
2130
1.54
7.64
5.5
4.1
ph
7.4
7.4
0.15
53
393
(3037121) Protein [Mass/volume] in Urine
59
270
2.28
7.63
4.9
3.2
g/l
0.2
0.2
1.84
40
106
(3026008) Bacteria identified in Urine by Culture
298
2227
1.53
7.51
4.0
3.4
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
205
1422
1.59
7.14
8.5
3.1
mmol/l
2.5
2.5
1.58
188
1244
(3027945) Reticulocytes/100 erythrocytes in Blood
142
904
1.69
6.95
2.1
2.5
%
1.8
1.8
0.24
125
808
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
82
442
1.95
6.94
1.6
1.4
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
51
229
2.31
6.91
1.3
1.2
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
68
346
2.05
6.76
6.3
4.2
mmol/l
23.7
24.1
0.38
63
313
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
139
898
1.66
6.41
2.1
1.8
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
44
199
2.28
5.89
1.8
1.4
ug/g
207.4
269.3
1.34
33
113
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
137
901
1.62
5.87
2.1
1.8
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
533
4603
1.45
5.87
6.1
4.6
—
—
—
0
0
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
69
372
1.93
5.85
1.5
1.9
g/l
1.7
1.6
0.49
59
327
(3008152) Bicarbonate [Moles/volume] in Arterial blood
87
506
1.80
5.83
9.8
7.1
mmol/l
23.8
24.5
1.24
82
475
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
38
163
2.40
5.74
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
38
163
2.40
5.74
1.3
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
59
306
2.00
5.60
1.9
1.8
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
112
710
1.67
5.54
1.5
1.6
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
696
6380
1.58
5.38
34.7
16.4
mg/l
40.5
26.8
16.99
644
5178
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
54
281
1.99
5.09
1.8
1.6
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
60
327
1.90
4.96
1.5
1.3
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
106
682
1.64
4.95
4.0
3.1
ng/l
249.1
243.9
0.04
97
629
(3019309) Folate [Moles/volume] in Red Blood Cells
204
1520
1.45
4.87
1.8
1.8
nmol/l
1112.4
1188.6
0.33
158
1134
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
192
1415
1.47
4.85
2.2
1.7
mg/l
1.9
1.3
2.23
165
1122
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
11
24
4.63
4.79
1.5
3.7
%
102.1
97.9
0.08
11
24
(4281824)
20
68
2.99
4.74
1.4
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
212
1609
1.43
4.55
1.3
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
460
3976
1.35
4.40
4.6
3.2
u/l
66.5
53.6
2.04
430
3631
(3020630) Protein [Mass/volume] in Serum or Plasma
98
647
1.58
4.13
2.2
3.0
g/l
65.6
66.2
0.28
90
593
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
13
37
3.55
4.06
1.5
2.0
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
76
478
1.65
3.90
4.5
3.2
g/l
116.7
126.0
2.58
76
468
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
50
280
1.84
3.85
2.5
2.7
g/l
3.5
3.2
1.20
41
225
(3048689) Calprotectin [Mass/mass] in Stool
97
651
1.56
3.81
3.9
2.1
ug/g
191.5
131.5
0.85
77
509
(40768797) Stomach Pathology biopsy report
130
931
1.47
3.76
1.3
1.2
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
90
597
1.57
3.72
4.8
2.9
kpa
4.7
4.4
0.84
85
574
(3024928) Oxygen saturation in Venous blood
34
169
2.06
3.69
4.1
2.9
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
101
690
1.53
3.67
2.0
2.7
e9/l
71.2
68.8
0.21
80
556
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
90
603
1.55
3.57
1.4
1.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
227
1813
1.35
3.48
1.8
1.6
nmol/l
20.7
20.5
0.05
200
1514
(3024139) IgG subclass 3 [Mass/volume] in Serum
15
53
2.86
3.37
1.3
1.2
g/l
0.5
0.4
—
9
39
(3027135) IgG subclass 1 [Mass/volume] in Serum
15
53
2.86
3.37
1.3
1.2
g/l
7.1
8.1
—
9
40
(3028192) IgG subclass 2 [Mass/volume] in Serum
15
53
2.86
3.37
1.3
1.2
g/l
2.7
2.7
—
8
39
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
10
27
3.74
3.36
1.9
2.0
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
12
37
3.28
3.35
1.6
1.9
%
11.5
14.8
—
6
17
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
51
301
1.74
3.33
2.5
2.6
g/l
8.3
7.4
2.25
41
231
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
51
301
1.74
3.33
2.5
2.6
g/l
4.7
3.7
2.44
40
222
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
51
301
1.74
3.33
2.5
2.6
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
115
824
1.46
3.32
2.0
1.4
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
30
149
2.05
3.29
1.5
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
150
1946
0.72
3.28
3.0
3.2
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
140
1044
1.41
3.26
21.6
28.4
inr
1.3
1.3
0.01
39
136
(3017143) Hepatitis C virus Ab [Presence] in Serum
83
560
1.54
3.21
1.4
1.6
—
—
—
0
0
(4062490)
15
55
2.76
3.16
1.3
1.2
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
260
2145
1.31
3.14
2.5
2.1
u/l
202.1
221.2
0.14
251
2013
(3021901) Oxygen saturation in Capillary blood
30
153
2.00
3.08
2.1
2.7
—
—
—
0
0
(3011648) Oxygen content in Venous blood
15
56
2.71
3.07
2.2
1.7
%
10.5
10.3
0.07
15
56
(3017817) Protein [Mass] in Urine collected for unspecified duration
17
69
2.49
2.97
1.4
2.6
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
47
281
1.71
2.96
2.0
2.7
g/l
10.2
10.7
0.28
41
244
(3013707) Erythrocyte sedimentation rate by Westergren method
533
4843
1.28
2.94
4.6
4.2
mm/h
19.2
14.0
6.38
487
4406
(3052592) Norovirus Ag [Presence] in Stool
7
13
5.42
2.87
1.3
1.5
—
—
—
0
0
(3019225) pH of Specimen
101
727
1.44
2.86
3.9
4.5
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
12
42
2.88
2.76
2.2
1.6
—
—
—
0
0
(3010421) pH of Blood
35
198
1.80
2.68
5.7
4.4
ph
7.4
7.4
0.07
30
158
(3003181) Sodium [Moles/volume] in Urine
26
133
1.99
2.68
1.4
1.3
mmol/l
61.8
61.3
0.03
18
112
(3021589) Normoblasts [#/volume] in Blood
329
2843
1.26
2.67
15.9
10.2
e9/l
0.0
0.0
0.14
259
2316
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
644
6029
1.31
2.64
30.9
15.5
ml/min/173m2
76.3
75.0
0.77
556
4991
(3004588) Protein electrophoresis panel - Serum or Plasma
78
543
1.48
2.63
2.2
2.6
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
32
178
1.83
2.59
1.6
1.7
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
15
62
2.45
2.55
1.3
1.3
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
43
263
1.67
2.53
2.4
3.9
mg/l
97.0
82.1
0.14
36
211
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
43
263
1.67
2.53
2.3
3.9
mg/l
52.1
43.8
0.22
36
212
(3024891) Influenza virus A+B Ag [Presence] in Specimen
29
158
1.87
2.51
1.2
1.2
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
21
102
2.09
2.49
1.4
1.3
e6/l
1465.3
1266.1
0.08
11
70
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
95
695
1.41
2.48
2.3
2.5
ug/l
8.8
6.5
0.33
82
606
(3004809) Band form neutrophils/100 leukocytes in Blood
23
116
2.01
2.47
2.3
3.7
%
2.7
1.1
1.16
15
100
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
311
2691
1.25
2.45
2.7
2.2
nmol/l
77.6
78.2
0.14
275
2330
(3026389) Candida sp identified in Specimen by Organism specific culture
17
77
2.23
2.39
1.5
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
11
40
2.77
2.38
1.4
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
595
5542
1.26
2.37
37.8
18.1
%
37.1
39.1
4.97
401
3540
(3028308) Erythrocytes [#/volume] in Pleural fluid
19
91
2.11
2.34
1.4
1.2
e6/l
1164.1
37024.8
—
9
52
(1616796) Gas panel - Central venous blood
29
163
1.81
2.30
4.7
3.9
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
705
6719
1.34
2.29
39.6
19.6
mmol/l
139.1
139.6
7.08
700
6522
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
54
359
1.54
2.29
4.7
2.5
%
0.6
0.7
0.33
54
348
(3012441) Differential panel - Pleural fluid
19
92
2.09
2.28
1.4
1.3
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
19
92
2.09
2.28
1.6
1.5
g/l
0.8
0.8
0.01
12
74
(40768806) Pleura Pathology biopsy report
20
99
2.05
2.27
1.2
1.5
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
8
23
3.50
2.27
1.3
2.2
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
17
79
2.18
2.26
2.0
2.6
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
706
6736
1.33
2.23
39.8
19.7
mmol/l
4.0
4.0
4.65
699
6531
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
27
150
1.83
2.22
1.3
1.3
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
69
487
1.45
2.20
3.2
3.7
mmol/l
2.6
1.8
0.81
46
366
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
69
488
1.45
2.18
1.7
1.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
29
166
1.77
2.18
1.1
1.3
—
—
—
0
0
(3020891) Body temperature
47
307
1.56
2.16
5.3
4.6
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
10
37
2.72
2.11
1.6
2.2
e9/l
0.1
0.2
—
10
32
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
5
10
5.02
2.07
1.0
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
7
20
3.52
2.06
1.6
3.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
53
362
1.50
2.01
1.2
1.4
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
70
506
1.42
1.99
2.7
2.8
g/l
10.1
10.6
0.42
63
461
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
71
519
1.40
1.90
3.4
3.6
kpa
5.2
5.1
0.24
66
484
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
30
183
1.66
1.84
1.8
1.5
iu/ml
0.0
30.1
—
9
40
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
10
40
2.52
1.84
1.4
1.3
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
6
17
3.55
1.84
1.5
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
17
87
1.97
1.81
1.6
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
158
1308
1.26
1.79
4.7
4.8
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
78
586
1.37
1.79
4.0
4.3
%
1.1
0.9
0.24
32
188
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
17
88
1.95
1.76
1.6
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
17
88
1.95
1.76
1.6
1.5
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
6
18
3.35
1.75
1.3
1.2
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
6
18
3.35
1.75
1.0
1.2
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
35
226
1.57
1.73
3.7
5.2
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
359
3238
1.19
1.73
5.0
4.1
estimate
0.0
0.0
0.50
65
583
(3002619) Bacteria identified in Specimen by Culture
5
13
3.86
1.71
1.0
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
17
89
1.93
1.71
1.6
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
17
89
1.93
1.71
1.6
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
17
89
1.93
1.71
1.6
1.4
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
35
228
1.56
1.67
1.3
1.6
—
154.5
—
0
11
(3006462) Nitrate [Presence] in Urine
8
31
2.60
1.66
4.9
3.4
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
54
388
1.42
1.62
5.2
4.2
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
54
389
1.42
1.60
2.5
2.5
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
207
1789
1.21
1.56
3.1
2.8
umol/l
385.1
8633.9
7.89
179
1517
(3009343) pH of Capillary blood
68
512
1.36
1.56
3.2
3.6
ph
7.4
7.4
—
6
66
(3011397) Hemoglobin [Presence] in Urine by Test strip
178
1519
1.22
1.53
4.1
4.0
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
5
15
3.35
1.52
1.6
1.4
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
314
2827
1.18
1.50
4.5
4.0
ng/l
30.9
55.8
1.21
259
2150
(3009508) Creatinine [Moles/volume] in Urine
251
2219
1.19
1.48
3.2
3.2
mmol/l
7.1
7.3
0.39
198
1819
(3021601) Nitrite [Presence] in Urine by Test strip
351
3193
1.17
1.47
6.9
5.5
estimate
0.0
0.0
0.00
65
602
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
9
38
2.38
1.46
1.7
2.1
e6/l
339.9
487.0
—
9
32
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
40
278
1.46
1.45
3.7
3.1
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
30
196
1.55
1.45
2.4
4.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
5
16
3.14
1.44
8.0
7.2
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
5
16
3.14
1.44
1.6
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
14
250
0.55
1.41
1.4
1.4
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
9
40
2.26
1.40
1.6
1.7
—
32.8
—
0
5
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
579
6067
0.85
1.38
6.8
6.4
mmol/mol
41.7
40.7
1.37
527
5523
(3037522) Nuclear Ab [Titer] in Serum
96
775
1.27
1.37
1.3
1.3
titre
266.7
440.9
1.42
18
178
(3008757) Leukocyte morphology finding [Identifier] in Blood
15
82
1.84
1.36
2.6
4.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
15
82
1.84
1.36
1.1
1.2
u/ml
2.2
6.9
—
6
38
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
5
17
2.95
1.36
8.0
7.4
—
—
—
0
0
(3036481) Cortisol [Moles/volume] in Serum or Plasma
75
587
1.31
1.35
2.6
2.0
nmol/l
401.3
372.7
0.56
68
533
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
14
75
1.88
1.35
1.1
1.1
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
0
39
0.00
1.34
0.0
1.3
—
31.7
—
0
32
(3004451) EKG impression Narrative
9
42
2.16
1.34
1.0
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
68
526
1.32
1.33
3.9
4.2
%
0.3
0.4
0.25
19
136
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
28
184
1.54
1.33
1.1
1.7
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
71
553
1.31
1.33
4.2
4.4
%
0.1
0.1
0.01
30
171
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
700
6766
1.23
1.33
19.6
11.1
u/l
25.2
25.7
0.33
684
6469
(3015235) Bicarbonate [Moles/volume] in Capillary blood
32
217
1.49
1.32
2.3
2.8
mmol/l
23.7
24.9
0.63
27
187
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
594
6204
0.85
1.32
4.5
4.7
mmol/l
1.4
1.4
3.46
541
5590
(3051611) Lipemic interference index of Serum or Plasma
14
76
1.86
1.30
5.8
3.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
349
3197
1.16
1.30
4.9
4.0
estimate
0.0
0.0
0.00
65
601
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
8
34
2.37
1.29
1.0
1.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
616
6409
0.85
1.27
5.0
5.3
mmol/l
2.6
2.6
1.40
560
5782
(3022313) Gas panel - Capillary blood
50
372
1.37
1.27
3.4
3.7
—
—
—
0
0
(4211845)
8
35
2.30
1.27
4.9
3.1
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
107
1.70
1.26
1.2
1.6
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
29
195
1.50
1.26
2.8
3.3
mg/l
1.7
1.8
0.22
24
178
(44816559) Phosphatidylethanol [Mass/volume] in Blood
5
116
0.43
1.26
1.0
1.2
—
—
—
0
0
(3013512) EKG study
244
2181
1.17
1.24
5.0
4.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
12
63
1.92
1.23
1.2
1.1
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
19
116
1.65
1.22
1.2
1.6
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
8
37
2.17
1.21
1.1
1.1
nmol/l
133.5
140.6
—
8
37
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
21
132
1.61
1.21
1.2
1.6
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
41
298
1.40
1.21
2.8
3.2
pmol/l
4.3
4.5
0.75
35
258
(3012516) Albumin [Mass/volume] in Urine
242
2169
1.16
1.19
3.4
3.2
mg/l
322.2
174.5
0.27
161
1404
(3020682) Albumin/Creatinine [Ratio] in Urine
256
2307
1.16
1.17
4.1
4.1
mg/mmol
17.0
9.1
1.19
164
1481
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
18
110
1.65
1.16
1.2
1.3
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
25
166
1.52
1.16
2.0
2.3
g/l
119.3
127.8
0.72
16
121
(3017354) Segmented neutrophils/100 leukocytes in Blood
13
72
1.82
1.15
1.8
3.5
%
66.0
53.1
—
7
56
(40768446) Kidney Pathology biopsy report
5
20
2.51
1.15
1.8
1.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
14
80
1.76
1.13
1.5
1.3
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
22
329
0.66
1.13
1.3
1.4
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
40
2.01
1.12
1.5
1.8
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
602
6254
0.86
1.11
4.4
4.7
mmol/l
4.4
4.5
0.73
552
5683
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
265
2404
1.15
1.10
3.4
3.1
ng/l
1392.5
1631.8
0.58
226
2072
(3022621) pH of Urine by Test strip
59
462
1.30
1.09
3.0
3.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
18
112
1.62
1.09
3.0
2.8
e9/l
5.6
4.6
0.37
18
112
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
5
21
2.39
1.09
1.0
1.6
ug/l
64.2
58.9
—
5
21
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
8
41
1.96
1.09
1.3
1.7
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
8
41
1.96
1.09
1.3
1.7
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
8
41
1.96
1.09
1.3
1.7
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
8
41
1.96
1.09
1.3
1.7
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
24
161
1.51
1.07
1.5
1.6
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
11
59
1.88
1.07
1.0
1.2
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
10
52
1.93
1.06
1.4
1.7
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
18
113
1.61
1.06
1.1
1.4
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
74
600
1.26
1.05
5.1
3.7
mmol/l
1.2
1.2
0.04
67
513
(3039443) Prostate specific Ag panel - Serum or Plasma
6
125
0.48
1.05
1.5
1.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
29
204
1.44
1.04
1.5
1.6
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
42
316
1.35
1.03
1.5
1.2
u/ml
162.3
191.1
0.24
37
287
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
71
575
1.26
1.02
4.5
3.8
ng/l
106.9
91.8
0.44
64
505
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
202
2246
0.87
1.00
4.5
4.6
%
22.2
21.3
0.35
101
1144
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
139
1590
0.85
1.00
3.1
3.2
ug/l
0.8
0.8
0.02
101
1092
(40767503) Oxygen content in Capillary blood by calculation
24
164
1.48
1.00
2.6
2.6
%
14.8
15.9
0.58
12
86
(3051651) Icteric interference index of Serum or Plasma
9
49
1.85
0.99
7.9
3.0
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
5
23
2.18
0.98
1.0
2.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
256
2796
0.88
0.98
4.9
5.4
ug/l
3.1
3.4
0.19
219
2460
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
16
100
1.61
0.97
1.9
1.9
—
—
—
0
0
(3012565) Volume of 24 hour Urine
7
36
1.95
0.97
1.3
2.4
ml
1742.9
1990.0
—
7
30
(3002385) Erythrocyte distribution width [Ratio]
536
5120
1.13
0.97
43.8
20.3
%
14.7
13.9
19.50
531
5012
(3044889) 12 lead EKG panel
495
4708
1.13
0.95
4.4
4.2
—
—
—
0
0
(4015189)
6
27
2.23
0.93
2.7
2.3
—
—
—
0
0
(4306422)
12
70
1.72
0.93
1.2
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
30
218
1.39
0.92
7.3
3.3
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
41
314
1.32
0.92
3.9
4.1
mmol/l
25.4
24.9
0.49
36
298
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
27
193
1.41
0.91
1.1
1.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
6
29
2.08
0.89
8.3
4.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
25
177
1.43
0.89
1.2
1.7
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
27
194
1.41
0.89
1.1
1.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
73
875
0.82
0.89
10.8
8.0
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
10
56
1.80
0.88
1.5
1.2
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
18
120
1.51
0.86
3.3
3.2
%
60.9
59.1
0.19
18
120
(42529406) Shigella sp [Presence] in Stool by Culture
27
196
1.39
0.85
1.1
1.2
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
6
31
1.94
0.84
1.3
1.9
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
6
31
1.94
0.84
1.3
1.9
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
8
45
1.79
0.84
1.3
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
8
45
1.79
0.84
1.3
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
8
45
1.79
0.84
1.3
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
8
45
1.79
0.84
1.3
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
8
45
1.79
0.84
1.3
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
8
45
1.79
0.84
1.3
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
10
57
1.76
0.84
1.2
1.4
—
—
—
0
0
(1002224) Polysomnography panel
13
202
0.64
0.83
1.0
1.1
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
6
32
1.88
0.82
1.3
1.9
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
22
155
1.43
0.81
1.9
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
39
303
1.30
0.81
1.3
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
188
1703
1.13
0.79
5.1
3.8
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
6
33
1.82
0.79
1.2
1.2
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
6
33
1.82
0.79
1.2
1.2
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
33
1.82
0.79
1.0
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
48
1.67
0.79
1.0
1.0
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
12
74
1.63
0.78
1.4
1.7
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
50
614
0.80
0.78
1.5
1.6
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
28
0.00
0.76
0.0
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
36
280
1.30
0.75
2.7
2.0
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
11
67
1.65
0.75
1.2
1.3
—
—
—
0
0
(44806118)
13
83
1.58
0.75
1.0
1.6
—
—
—
0
0
(44790049)
13
83
1.58
0.75
1.0
1.6
—
—
—
0
0
(44790047)
13
83
1.58
0.75
1.0
1.6
—
—
—
0
0
(44790048)
13
83
1.58
0.75
1.0
1.6
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
713
6979
1.16
0.75
48.6
24.2
e9/l
258.4
241.6
6.41
694
6777
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
88
757
1.18
0.75
6.4
3.6
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
17
116
1.48
0.74
5.6
2.7
—
—
—
0
0
(3024731) MCV [Entitic volume]
713
6981
1.16
0.73
48.4
24.1
fl
91.1
91.6
1.52
706
6846
(3035941) MCH [Entitic mass]
713
6981
1.16
0.73
48.4
24.1
pg
30.0
30.4
6.16
706
6845
(3026361) Erythrocytes [#/volume] in Blood
713
6982
1.16
0.73
48.5
24.2
e12/l
4.2
4.4
16.71
690
6752
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
14
92
1.53
0.72
2.4
1.5
%
72.6
63.3
—
8
64
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
7
39
1.80
0.72
1.0
1.3
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
7
39
1.80
0.72
1.0
1.3
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
35
273
1.29
0.72
2.3
1.9
u/l
39.2
38.3
0.08
27
235
(3000963) Hemoglobin [Mass/volume] in Blood
713
6983
1.16
0.72
49.0
24.3
g/l
125.6
133.9
30.32
705
6842
(4010399)
57
473
1.22
0.71
1.5
1.4
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
674
6580
1.13
0.70
30.6
15.7
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
79
915
0.85
0.69
4.9
4.7
%
33.9
32.2
0.54
48
599
(3014051) Protein [Presence] in Urine by Test strip
22
161
1.38
0.69
3.2
2.3
—
—
—
0
0
(4268621)
10
61
1.65
0.68
2.2
2.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
7
43
1.63
0.67
1.4
1.7
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
5
28
1.79
0.66
1.0
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
16
111
1.45
0.66
3.6
2.6
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
7
44
1.60
0.65
1.4
1.7
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
712
6984
1.14
0.64
48.7
24.2
e9/l
7.4
6.9
4.31
691
6758
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
26
199
1.32
0.63
1.8
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
15
104
1.45
0.62
1.3
1.6
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
11
71
1.56
0.62
1.2
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
11
71
1.56
0.62
1.2
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
11
71
1.56
0.62
1.2
1.7
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
6
104
0.57
0.62
1.2
1.3
u/l
8.9
9.5
—
6
79
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
158
1728
0.89
0.61
1.6
1.7
mmol/l
1.5
1.3
0.97
124
1411
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
5
30
1.67
0.61
1.0
1.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
23
300
0.76
0.61
1.5
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
13
88
1.48
0.61
1.2
1.7
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
170
1558
1.11
0.60
1.7
1.8
pmol/l
92701132.7
9308307.8
0.43
137
1257
(3035880) pH of Pleural fluid
8
51
1.57
0.60
1.1
1.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
263
2466
1.10
0.60
5.2
4.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
613
6279
0.91
0.58
4.8
5.0
mmol/l
6.2
6.1
1.57
550
5600
(3028026) IgM [Mass/volume] in Serum or Plasma
48
402
1.21
0.57
2.1
1.8
g/l
1.6
1.5
0.04
42
363
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
11
161
0.68
0.57
1.8
1.7
nmol/l
40.0
41.1
0.09
11
152
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
26
203
1.29
0.56
1.5
1.5
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
29
362
0.79
0.56
1.7
1.8
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
10
65
1.55
0.55
1.0
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
6
37
1.63
0.55
14.7
16.5
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
16
116
1.39
0.54
1.2
1.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
14
99
1.42
0.54
1.9
1.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
14
99
1.42
0.54
1.1
1.1
—
—
—
0
0
(3022806) Fractional oxyhemoglobin in Capillary blood
14
100
1.41
0.52
2.6
1.9
%
87.5
89.2
0.28
14
100
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
14
100
1.41
0.52
1.3
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
31
251
1.24
0.51
1.1
1.3
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
6
40
1.50
0.51
1.5
1.8
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
11
157
0.70
0.51
1.1
1.2
—
6.1
—
0
26
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
68
595
1.16
0.51
2.0
1.8
%
1.5
1.6
0.74
58
505
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
13
92
1.42
0.50
1.0
1.0
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
6
41
1.47
0.50
1.3
2.0
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
12
166
0.72
0.48
1.2
1.2
—
2.9
—
0
10
(3019150) Specific gravity of Urine by Refractometry
154
1424
1.10
0.48
4.3
4.5
kg/l
1.0
1.0
0.87
27
199
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
7
47
1.49
0.47
1.6
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
7
47
1.49
0.47
1.6
1.3
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
11
154
0.71
0.47
1.1
1.2
—
2.2
—
0
18
(3021788) Differential panel - Synovial fluid
17
129
1.32
0.46
1.8
1.5
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
7
49
1.43
0.46
1.1
1.0
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
30
247
1.22
0.44
1.1
1.0
—
—
—
0
0
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
9
129
0.69
0.43
1.0
1.2
—
9.2
—
0
10
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
14
104
1.35
0.43
1.1
1.1
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
5
31
1.62
0.43
1.0
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
8
56
1.43
0.42
1.4
1.2
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
59
520
1.14
0.42
4.6
4.4
%
0.0
0.7
0.59
23
144
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
8
57
1.41
0.42
1.1
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
55
624
0.87
0.41
2.7
3.5
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
14
105
1.34
0.41
5.1
2.6
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
16
123
1.31
0.40
1.6
1.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
17
132
1.29
0.40
1.6
1.6
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
0
18
0.00
0.40
0.0
1.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
14
182
0.77
0.39
1.2
1.2
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
15
115
1.31
0.39
1.1
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
11
80
1.38
0.38
1.7
2.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
5
37
1.35
0.37
2.0
2.0
—
—
—
0
0
(44813793)
5
37
1.35
0.37
1.0
1.0
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
10
135
0.74
0.36
1.0
1.2
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
5
78
0.64
0.35
1.0
1.2
—
78.7
—
0
5
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
22
181
1.22
0.34
1.3
1.3
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
6
44
1.37
0.34
1.7
3.2
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
61
549
1.12
0.34
3.2
3.1
ml/min/173m2
67.4
59.3
0.71
32
226
(3000012) Reticulocyte production index
6
45
1.34
0.34
1.2
2.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
14
109
1.29
0.33
1.1
1.5
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
41
360
1.15
0.33
6.7
3.8
%
48.6
46.3
0.25
41
354
(3017704) Immunofixation for Urine
6
47
1.28
0.32
1.2
1.7
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
17
137
1.25
0.32
1.2
1.7
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
21
174
1.21
0.31
2.0
1.6
e6/l
20311.0
16680.7
0.15
13
126
(3029937) Albumin [Presence] in Urine by Test strip
169
1780
0.94
0.31
5.5
4.4
estimate
0.0
0.0
0.69
60
570
(3021387) Prolactin [Units/volume] in Serum or Plasma
7
100
0.70
0.30
1.3
1.8
mu/l
236.7
272.6
—
7
94
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
13
102
1.28
0.30
1.1
1.3
u/ml
363.1
301.7
—
7
55
(3016650) Hepatitis A virus Ab [Presence] in Serum
12
93
1.29
0.30
1.1
1.1
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
7
55
1.28
0.30
1.1
1.9
mmol/l
6.3
6.8
—
7
32
(3001019) Free T4 and TSH panel - Serum or Plasma
12
152
0.79
0.29
1.0
1.8
—
—
—
0
0
(3000492) Spirometry study
61
555
1.11
0.29
1.5
1.5
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
592
6011
0.95
0.28
4.1
4.2
mmol/l
1.4
1.3
4.32
538
5379
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
11
85
1.30
0.28
1.5
1.3
—
0.7
—
0
6
(3027944) Amphetamines [Presence] in Urine
11
85
1.30
0.28
1.1
1.4
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
8
62
1.29
0.28
1.0
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
8
63
1.27
0.28
1.3
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
8
63
1.27
0.28
1.6
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
8
64
1.25
0.27
1.1
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
8
66
1.21
0.26
1.4
1.7
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
8
66
1.21
0.26
1.3
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
11
86
1.28
0.26
1.1
1.4
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
11
86
1.28
0.26
1.5
1.3
nmol/l
0.6
0.6
0.04
11
78
(3027008) Opiates [Presence] in Urine
11
86
1.28
0.26
1.1
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
17
142
1.20
0.24
1.2
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
9
76
1.19
0.24
1.2
1.9
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
5
39
1.28
0.23
1.0
1.3
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
16
189
0.84
0.22
1.4
1.8
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
5
40
1.25
0.22
2.0
1.8
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
40
1.25
0.22
2.2
2.5
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
42
1.19
0.21
1.6
1.6
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
5
42
1.19
0.21
1.2
1.5
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
0
12
0.00
0.21
0.0
1.7
—
1.2
—
0
12
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
94
994
0.94
0.21
1.2
1.3
iu/ml
57.2
38.0
0.42
24
305
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
14
166
0.84
0.20
1.6
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
10
80
1.25
0.20
1.1
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
10
80
1.25
0.20
1.3
1.3
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
6
51
1.18
0.19
1.8
2.8
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
10
81
1.24
0.19
1.2
1.9
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
10
81
1.24
0.19
1.6
1.3
nmol/l
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
6
53
1.13
0.18
4.7
2.6
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
13
109
1.20
0.18
1.5
2.3
pg
31.5
32.3
0.33
13
109
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
13
109
1.20
0.18
1.1
1.2
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
7
58
1.21
0.18
1.1
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
38
348
1.10
0.18
3.0
2.8
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
45
416
1.09
0.18
1.2
1.2
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
7
60
1.17
0.18
1.4
1.4
u/l
15.6
13.8
—
7
54
(3019832) Treponema pallidum Ab [Presence] in Serum
27
243
1.11
0.17
1.2
1.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
13
110
1.18
0.17
1.2
1.7
—
—
—
0
0
(4024509)
7
63
1.11
0.17
1.7
1.3
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
7
63
1.11
0.17
1.3
1.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
99
945
1.05
0.17
1.2
1.3
u/ml
28.7
11.8
0.62
28
341
(3007164) IgA [Mass/volume] in Serum or Plasma
115
1104
1.05
0.16
1.5
1.5
g/l
3.3
2.7
0.90
73
644
(4146454)
11
92
1.20
0.16
2.7
2.6
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
6
79
0.76
0.15
2.7
4.0
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
10
83
1.21
0.15
2.2
1.8
—
—
—
0
0
(21494434) Karyotype in Bone marrow
9
78
1.16
0.15
1.0
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
11
94
1.17
0.13
1.1
1.4
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
10
85
1.18
0.12
1.1
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
67
642
1.05
0.11
1.4
1.3
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
17
187
0.91
0.10
2.4
2.5
ug/min
176.8
101.8
0.23
11
106
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
576
5800
0.98
0.10
5.2
4.7
mu/l
2.0
2.2
0.33
518
5172
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
471
4751
0.98
0.09
4.2
3.8
pmol/l
14.6
15.0
3.02
424
4210
(3017569) Oxygen content in Arterial blood
5
48
1.04
0.09
2.0
3.1
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
6
54
1.11
0.09
2.5
2.4
—
98.2
—
0
9
(3011288) Drugs identified in Urine by Screen method
6
55
1.09
0.09
1.0
1.7
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
6
57
1.05
0.08
1.0
1.1
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
6
58
1.03
0.08
1.0
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
6
58
1.03
0.08
1.0
1.1
—
—
—
0
0
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
7
64
1.09
0.08
1.4
1.2
u/l
7.4
13.9
—
7
56
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
65
1.08
0.08
1.3
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
26
276
0.94
0.07
1.8
1.7
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
8
75
1.07
0.07
1.3
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
36
377
0.95
0.07
1.2
1.3
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
14
128
1.10
0.06
1.2
1.1
—
—
—
0
0
(40768793) Breast Pathology biopsy report
15
138
1.09
0.06
1.3
1.3
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
77
751
1.03
0.06
1.4
1.3
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
121
1230
0.98
0.05
1.2
1.2
u/ml
10.5
1.3
0.75
25
313
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
321
3232
0.99
0.04
2.5
2.5
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
12
111
1.08
0.04
1.2
1.1
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
17
161
1.06
0.03
1.1
1.2
mg/l
434.9
501.7
0.62
17
147
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
11
118
0.93
0.02
2.0
1.8
pmol/l
187.0
229.7
0.69
11
110
(4094501)
16
168
0.95
0.02
1.2
1.1
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
11
117
0.94
0.01
6.5
2.9
—
—
—
0
0
(4034850)
19
196
0.97
0.00
13.4
11.3
—
—
—
0
0
(3008898) HLA-B27 [Presence]
15
155
0.97
0.00
1.0
1.1
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
25
245
1.02
0.00
1.7
1.7
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
12
123
0.98
0.00
1.2
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
42
416
1.01
0.00
4.5
3.0
e9/l
4.1
4.0
0.07
27
306
(40761536) Microorganisms panel - Urine sediment
56
564
0.99
0.00
7.2
4.0
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
16
159
1.01
0.00
5.0
3.9
mg/l
46.7
31.4
0.43
11
100
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
23.4
—
0
7
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
8
85
0.94
0.00
1.1
1.0
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
8
87
0.92
0.00
1.1
1.3
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
6
67
0.89
0.00
1.3
1.2
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
5
50
1.00
0.00
1.0
1.1
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
9
90
1.00
0.00
5.2
4.4
umol/l
303.1
358.3
—
9
81
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
74
0.95
0.00
1.0
1.1
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013762) Body weight Measured
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3044416) Complement C4 [Mass/volume] in Pleural fluid
0
5
0.00
0.00
0.0
1.0
—
0.1
—
0
5
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
9
0.00
-0.00
0.0
3.1
—
82.8
—
0
9
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
0
9
0.00
-0.00
0.0
1.0
—
6.8
—
0
9
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
9
0.00
-0.00
0.0
1.6
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: OPER_JFB43 – Left hemicolectomy

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).